The demand for clinical drug testing in the field of pain management has increased dramatically as clinicians, regulatory agencies and insurance payers seek objective measures to enhance and augment pharmacotherapy, monitor pharmacotherapeutic compliance, assess treatment efficacy, and identify individuals at risk following the use or misuse of illicit substances, prescription drugs, over the c